Goldman Sachs Group Inc. Sells 3,201 Shares of American Renal Associates Holdings, Inc (ARA)

Goldman Sachs Group Inc. lowered its stake in American Renal Associates Holdings, Inc (NYSE:ARA) by 0.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 709,207 shares of the company’s stock after selling 3,201 shares during the period. Goldman Sachs Group Inc. owned about 2.28% of American Renal Associates Holdings worth $11,971,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Atria Investments LLC bought a new position in shares of American Renal Associates Holdings during the first quarter valued at approximately $181,000. Oxford Asset Management acquired a new position in shares of American Renal Associates Holdings during the first quarter worth about $237,000. Lucus Advisors LLC acquired a new position in shares of American Renal Associates Holdings during the first quarter worth about $295,000. Martingale Asset Management L P acquired a new position in shares of American Renal Associates Holdings during the first quarter worth about $372,000. Finally, Teachers Advisors LLC increased its position in shares of American Renal Associates Holdings by 42.6% in the fourth quarter. Teachers Advisors LLC now owns 20,092 shares of the company’s stock worth $428,000 after buying an additional 6,000 shares in the last quarter. 87.58% of the stock is currently owned by hedge funds and other institutional investors.

Shares of American Renal Associates Holdings, Inc (NYSE ARA) opened at 18.81 on Tuesday. The company has a 50-day moving average price of $17.49 and a 200-day moving average price of $19.01. The company’s market capitalization is $585.95 million. American Renal Associates Holdings, Inc has a 12 month low of $15.11 and a 12 month high of $26.94.

American Renal Associates Holdings (NYSE:ARA) last issued its quarterly earnings data on Tuesday, May 9th. The company reported $0.06 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.10 by $0.04. American Renal Associates Holdings had a positive return on equity of 20.97% and a negative net margin of 2.13%. The company had revenue of $177 million during the quarter, compared to analysts’ expectations of $184.67 million. During the same quarter last year, the business earned $0.16 earnings per share. The business’s quarterly revenue was up 2.8% on a year-over-year basis. On average, equities analysts anticipate that American Renal Associates Holdings, Inc will post $0.53 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Goldman Sachs Group Inc. Sells 3,201 Shares of American Renal Associates Holdings, Inc (ARA)” was published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at https://sportsperspectives.com/2017/07/18/goldman-sachs-group-inc-sells-3201-shares-of-american-renal-associates-holdings-inc-ara.html.

A number of brokerages have recently issued reports on ARA. Zacks Investment Research raised American Renal Associates Holdings from a “hold” rating to a “buy” rating and set a $20.00 price objective on the stock in a research note on Tuesday, July 11th. Wells Fargo & Company raised American Renal Associates Holdings from a “market perform” rating to an “outperform” rating in a research note on Thursday, May 11th. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $25.50.

American Renal Associates Holdings Company Profile

American Renal Associates Holdings, Inc is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia.

Institutional Ownership by Quarter for American Renal Associates Holdings (NYSE:ARA)

Receive News & Ratings for American Renal Associates Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply